Vilnius, Lithuania

Vytautas Cepla


 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Vytautas Cepla: Innovator in Bioactive Delivery Systems and Regenerative Medicine

Introduction

Vytautas Cepla is a notable inventor based in Vilnius, Lithuania. He has made significant contributions to the fields of bioactive compound delivery and regenerative medicine. With a total of two patents to his name, Cepla's work is paving the way for advancements in medical technology.

Latest Patents

Cepla's latest patents include a "Bioactive Compound Delivery Assembly," which focuses on the stabilization and encapsulation of bioactive compound compositions. This invention also details a method for solid-supported transfection of living cells, showcasing its potential applications in biotechnology. Another significant patent is for "Regenerative Prostheses as Alternatives to Donor Corneas for Transplantation." This invention describes a corneal implant that features a matrix material with an anti-fouling core part, designed to inhibit cell proliferation. The patent also outlines methods for preparing the product and its various uses.

Career Highlights

Throughout his career, Cepla has worked with various organizations, including UAB Ferentis and Universitat Heidelberg. His experience in these institutions has contributed to his innovative research and development efforts in the medical field.

Collaborations

Some of Cepla's notable coworkers include Ramunas Valiokas and Jaywant Babasaheb Phopase. Their collaborative efforts have likely enhanced the scope and impact of his inventions.

Conclusion

Vytautas Cepla's contributions to bioactive delivery systems and regenerative medicine highlight his role as a forward-thinking inventor. His patents reflect a commitment to advancing medical technology and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…